NDC 0003-0050 – Cobenfy
Xanomeline 50 mg/1; Trospium Chloride 20 mg/1 · Capsule, Coated Pellets · Oral
Product NDC0003-0050
Product details
- Brand name
- Cobenfy
- Generic name
- Xanomeline and trospium chloride
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Dosage form
- Capsule, Coated Pellets
- Route
- Oral
- Marketing category
- NDA · NDA216158
- Marketed since
- September 27, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Cholinergic Muscarinic Agonist; Cholinergic Muscarinic Antagonist
Active ingredients
- Xanomeline 50 mg/1
- Trospium Chloride 20 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 0003-0050-14 sample | 14 CAPSULE, COATED PELLETS in 1 BLISTER PACK (0003-0050-14) | Sep 27, 2024 |
| 0003-0050-60 | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (0003-0050-60) | Sep 27, 2024 |
| 0003-0050-98 | 10 BLISTER PACK in 1 CARTON (0003-0050-98) / 10 CAPSULE, COATED PELLETS in 1 BLISTER PACK | Jun 15, 2026 |
Other Cobenfy products
- 0003-0125 Xanomeline 125 mg/1; Trospium Chloride 30 mg/1 · Capsule, Coated Pellets · E.R. Squibb & Sons, L.L.C.
- 0003-1100 Xanomeline 100 mg/1; Trospium Chloride 20 mg/1 · Capsule, Coated Pellets · E.R. Squibb & Sons, L.L.C.
- 0003-5150 · Kit · E.R. Squibb & Sons, L.L.C.
- 0003-5200 · Kit · E.R. Squibb & Sons, L.L.C.